Skip to main content
Earnings Labs
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG)

NASDAQ·Healthcare·Biotechnology

$22.75

—

Mkt Cap $204.19M

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (8 analysts)

$171.67

Range $145.00 – $220.00

Implied Upside

+654.6%

Consensus $171.67 vs current $22.75